Toyota|$17.70 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.57 (¥4,246)+1.10%▲ (in JPY terms)
SoftBank|$24.67 (¥3,941)+2.23%▲ (in JPY terms)
MUFG|$21.90 (¥3,499)-0.09%▼ (in JPY terms)
Keyence|$476.41 (¥76,120)+0.53%▲ (in JPY terms)
Nintendo|$53.08 (¥8,481)+1.31%▲ (in JPY terms)
NTT|$1.04 (¥166)+2.22%▲ (in JPY terms)
Takeda|$42.37 (¥6,770)+1.45%▲ (in JPY terms)
Tokyo Electron|$60.58 (¥9,679)+4.39%▲ (in JPY terms)
Recruit|$104.68 (¥16,725)-5.54%▼ (in JPY terms)
ITOCHU|$15.04 (¥2,403)+1.18%▲ (in JPY terms)
Honda|$11.23 (¥1,795)+1.44%▲ (in JPY terms)
Shin-Etsu|$37.10 (¥5,928)+3.84%▲ (in JPY terms)
Tokio Marine|$3.69 (¥590)-0.39%▼ (in JPY terms)
Fast Retailing|$507.51 (¥81,090)+0.76%▲ (in JPY terms)
Toyota|$17.70 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.57 (¥4,246)+1.10%▲ (in JPY terms)
SoftBank|$24.67 (¥3,941)+2.23%▲ (in JPY terms)
MUFG|$21.90 (¥3,499)-0.09%▼ (in JPY terms)
Keyence|$476.41 (¥76,120)+0.53%▲ (in JPY terms)
Nintendo|$53.08 (¥8,481)+1.31%▲ (in JPY terms)
NTT|$1.04 (¥166)+2.22%▲ (in JPY terms)
Takeda|$42.37 (¥6,770)+1.45%▲ (in JPY terms)
Tokyo Electron|$60.58 (¥9,679)+4.39%▲ (in JPY terms)
Recruit|$104.68 (¥16,725)-5.54%▼ (in JPY terms)
ITOCHU|$15.04 (¥2,403)+1.18%▲ (in JPY terms)
Honda|$11.23 (¥1,795)+1.44%▲ (in JPY terms)
Shin-Etsu|$37.10 (¥5,928)+3.84%▲ (in JPY terms)
Tokio Marine|$3.69 (¥590)-0.39%▼ (in JPY terms)
Fast Retailing|$507.51 (¥81,090)+0.76%▲ (in JPY terms)

admin

2026-09-16 DAIICHI SANKYO COMPANY,LIMITED “Notice of two partial amendments to the approval of the anti-cancer drugs "Enhertu®" and "Datroway®" for the first-line treatment of metastatic breast cancer in Japan (257.4KB) PDF file will be displayed in a new window.”

by

2026-09-16 DAIICHI SANKYO COMPANY,LIMITED “Notice of two partial amendments to the approval of the anti- … 続きを読む

2026-09-16 Eisai Co.,Ltd. “Rekenbi®, a subcutaneous injection formulation of the early-stage Alzheimer's disease treatment drug Rekenbi®, has received approval in Japan—the first and only home-administered anti-amyloid therapy for Alzheimer's disease in Japan.”

by

2026-09-16 Eisai Co.,Ltd. “Rekenbi®, a subcutaneous injection formulation of the early-stage Alzheimer&# … 続きを読む

2026-09-16 Shionogi & Co.,Ltd. “Regarding the acquisition of manufacturing and marketing approval for the addition of dosage and administration instructions for "Vitamer® Cream" in Japan for the treatment of atopic dermatitis in children (under 12 years of age).”

by

2026-09-16 Shionogi & Co.,Ltd. “Regarding the acquisition of manufacturing and marketing approval f … 続きを読む

2026-09-16 Nomura Research Institute,Ltd. “September 16, 2026 Announcement: Nomura Research Institute and Mitsubishi Heavy Industries begin joint studies and practical activities on business process reform utilizing digital technologies, including AI.”

by

2026-09-16 Nomura Research Institute,Ltd. “September 16, 2026 Announcement: Nomura Research Institute an … 続きを読む

2026-09-16 Resonac Holdings Corporation “Resonaq, in collaboration with Matlantis, has demonstrated a new feature for experimental chemists, "Matlantis Case Studio," which supports "ambidextrous" skills in both experimental and computational science. An alpha version of "Matlantis Case Studio" is planned for release.”

by

2026-09-16 Resonac Holdings Corporation “Resonaq, in collaboration with Matlantis, has demonstrated a ne … 続きを読む

Sister site: Lagrange Financial News (Japanese-language)
Contact